Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 21, 2015; 21(7): 2089-2095
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2089
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2089
Figure 2 Cumulative emergence rates of virological breakthrough and the cumulative breakthrough hepatitis rates in both groups.
A: The cumulative emergence rates of virological breakthrough; B: The cumulative breakthrough hepatitis rates. YMDD: Tyrosine-methionine-aspartic acid- aspartic acid.
- Citation: Tan YW, Ye Y, Ge GH, Zhao W, Gan JH, Zhao Y, Niu ZL, Zhang DJ, Chen L, Yu XJ, Yang LJ. Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B. World J Gastroenterol 2015; 21(7): 2089-2095
- URL: https://www.wjgnet.com/1007-9327/full/v21/i7/2089.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i7.2089